The EMEA reported results from some clinical trials in the CHMP Assessment Report. These relate to vaccination against H5N1 (Bird Flu) and not H1N1 (Swine Flu). * H5N1-007 was initiated at a single site in Belgium (Ghent) in March 2006. * H5N1-008 was initiated at 41 sites in seven countries (6 EU MS plus Russia) in May 2006. * H5N1-002 was initiated on 24 March 2007 in four SE Asian countries. GlaxoSmithKline reported results from the second clinical trial, from the pediatric clinical trial, and the response from the elderly population.
Pandemrix
Spanish flu
Polymeal
London flu
STOVIA
Chinese virus
Rubella
Morgellons